QuidelOrtho Corporation QDEL Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value at other companies

CHE

ChemedCHE

85.8-25.1%

HTF

Heartflow, Inc. Common StockHTFL

15.9+124%

BeldenBDC

$39.44+80.5%

KEE

Keel Infrastructure Corp. Common StockKEEL

$0.72-35.7%

KEE

Keel Infrastructure Corp. Common StockKEEL

$1.08+4.9%

Boston BeerSAM

$343.91-10.0%

Other financials

Income statement

See full

Revenue$619.8M-10.5%

Gross profit$263.8M-23.2%

Operating income-$31.8M-198%

Net income-$91.8M-623%

EPS (diluted)-$1.35-611%

Balance sheet

See full

Cash & equivalents$140.4M+10.4%

Total debt$3.1B+0.3%

Total equity$1.9B-38.2%

Total assets$5.6B-12.9%

Cash flow

See full

Operating cash flow-$33.0M-150%

CapEx$34.0M-39.5%

Free cash flow-$67.0M-813%

Valuation

See full

Market cap$832.61M-51.4%

Enterprise value$3.8B-20.1%

P/S0.3×-0.3×

Profitability

See full

Gross margin45%-2.0pp

Operating margin-37%-46.2pp

Net margin-45.6%-75.7pp

FCF margin13.8%—

Returns & leverage

See full

Return on equity-49.9%-70.8pp

Debt / equity1.7×+0.6×

Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is QuidelOrtho Corporation's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value?: QuidelOrtho Corporation (QDEL) reported share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value of $17.83 in Q4 2025.
What does share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value mean?: The weighted-average fair value at the grant date for stock options awarded to employees. This figure is used to determine the total compensation expense to be recognized over the vesting period of the options.